What is "lipoglycopeptide"

n. Any of a class of antibiotics with lipophilic side chains linked to glycopeptides.

Lipoglycopeptides are a class of antibiotic that have lipophilic side-chains linked to glycopeptides. The class includes oritavancin, telavancin and dalbavancin.

In September 2009 the FDA approved Vibativ (telavancin) for complicated skin and skin structure infections (cSSSI) On May 23, 2014 FDA approved Dalvance (dalbavancin), an injectable drug, administered intravenously in two doses one week apart. On August 6, 2014 FDA approved Orbactiv (oritavancin), an injectable drug administered as a single dose to comprise a full course of therapy.

Telavancin is the most potent of the 3 against Clostridium spp.